login
login

Europe Daily Bulletin No. 7636

19 January 2000
Contents Publication in full By article 43 / 56
ECONOMIC INTERPENETRATION / (eu) pharmaceuticals

The Swiss firm NOVRATIS is to invest FF 544 million on its French site of Huningue to produce an innovative medicine against asthma and allergy, allowing for the creation of 100 new jobs.

Contents

THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION